Ambulantná terapia 2/2007
PHARMACOTHERAPY OF BENIGN PROSTATIC HYPERPLASIA, PREVENTION, EFFECTIVE MEDICATIONS, ADVERSE EVENTS
Benign prostatic hyperplasia is common disease of aging men. The therapy has made great improvements in the last the fifteen years. The most common mode of treatment is pharmacotherapy. The most effective drugs are alpha 1-adrenergic blockers and 5-alpha reductase inhibitors, possibly a combination of these drugs. The authors describe current pharmacotherapy, its efficacy and adverse events.
Keywords: benign prostatic hyperplasia, pharmacotherapy, phytotherapy, alpha-blocker, 5-alpha-reductase inhibitor
